Abstract
This commentary outlines the steps taken by the New Orleans Louisiana Neuroendocrine Tumor Specialists to minimize the risk of patient exposure to SARS‐CoV‐2 but to continue to provide safe, high‐quality care during the COVID‐19 pandemic.
Keywords:
COVID-19; Neuroendocrine tumors; New Orleans Louisiana Neuroendocrine Tumor Specialists.
MeSH terms
-
Betacoronavirus / pathogenicity*
-
COVID-19
-
Cancer Care Facilities / organization & administration
-
Cancer Care Facilities / standards*
-
Continuity of Patient Care / organization & administration
-
Continuity of Patient Care / standards
-
Coronavirus Infections / epidemiology
-
Coronavirus Infections / prevention & control*
-
Coronavirus Infections / transmission
-
Coronavirus Infections / virology
-
Humans
-
Infection Control / organization & administration
-
Infection Control / standards
-
Medical Oncology / organization & administration
-
Medical Oncology / standards*
-
Neuroendocrine Tumors / therapy*
-
New Orleans / epidemiology
-
Pandemics / prevention & control*
-
Pneumonia, Viral / epidemiology
-
Pneumonia, Viral / prevention & control*
-
Pneumonia, Viral / transmission
-
Pneumonia, Viral / virology
-
Practice Guidelines as Topic
-
SARS-CoV-2